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Abstract
Background: Universal BCG vaccination in the UK ended in 2005. The new vaccination policy
instead offers a number of different forms of selective vaccination to newborns based on risk of
acquiring TB. We set out to assess the attitudes and knowledge of both parents and professionals
to the new policy for neonatal BCG vaccination.
Methods: A short questionnaire was designed, made up of demographic and attitude questions,
as well as very basic knowledge questions. The researchers handed out the questionnaire to all
parents and professionals in the antenatal and postnatal areas, as well as the paediatric and neonatal
units during a 6-week period. The site was the Royal Oldham hospital, a district general hospital
with 3250 deliveries per year and multi-ethnic in its population mix.
Results: A total of 253 completed questionnaires were collected. The ethnic origin of responders
was 50.6% White British, 18.2% Bangladeshi, 8.7% Indian, 4% White/Asian, the remaining 18.5% of
other origins. 71.5% of responders said they had heard of BCG vaccine. When asked if they knew
the new policy for its use, 33.2% answered yes. 24.5% gave the most accurate response when asked
who now receives BCG.
Conclusion: We have found that amongst parents and professionals alike there is a lack of
knowledge of the new policy. This has lead to confusion and as knowledge amongst the
professionals who identify neonates for vaccination is low, uptake may be sub-optimal. We suggest
that units investigate the issue and ensure that the new policy is understood and implemented
correctly.
Background
The UK BCG vaccination strategy for the last 50 years was
based on universal vaccination of teenage school children
if they had not previously been vaccinated, offering pro-
tection to the young adults in whom TB was most preva-
lent and most likely to be infectious [1,2]. In more recent
years, a policy of selective vaccination was also introduced
[3], providing protection to new immigrants and new-
borns perceived to be at high risk. Indeed, the BCG vac-
cine for newborns and infants has been shown to offer
significant protection against TB [4]
Based on the changing make up of the UK population and
the declining rates of TB in the age group in whom univer-
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sal vaccination was taking place, the joint committee on
vaccination and immunisation introduced new guidelines
in July 2005, which were then made policy by the depart-
ment of health [5]. The new policy [6] abolishes universal
vaccination and instead offers vaccination to all newborns
in areas of high TB incidence and selective vaccination in
other areas, based on the country of origin of parents and
grandparents [7].
We set out to assess the attitudes and knowledge of both
parents and professionals to the new policy for the use of
the BCG vaccine at the Royal Oldham hospital, a district
general hospital with 3250 deliveries per year and multi-
ethnic in its population mix.
Methods
A short questionnaire was designed [see Additional file 1],
made up of demographic and attitude questions, as well
as very basic knowledge questions. This was piloted on a
random sample of parents and professionals to check the
clarity of the questions and appropriate language changes
were made to allow the questions to gather the informa-
tion required. The researchers handed out the question-
naire to all parents and professionals in the antenatal and
postnatal areas, as well as the paediatric and neonatal
units during a 6-week period. Health care workers who do
not work in antenatal, postnatal or neonatal units were
not asked to complete the questionnaire. A brief descrip-
tion of the study and explanation that participation was
optional accompanied the questionnaire, no other guid-
ance being offered by the interviewers. If a question was
not understood, participants were asked to leave it blank.
Patients who did not speak English were offered the use of
the resident interpreters to complete the questionnaire.
The completed questionnaires were collected immedi-
ately and data was coded and entered into SPSS for Win-
dows version 11.5 for descriptive analysis (SPSS Inc,
Chicago, USA).
Results
A total of 253 completed questionnaires were collected.
No one declined to take part in the study. Responders
were made up of parents and professionals, consisting of
133 parents (52.6%), 63 midwifes (24.9%), 26 nurses
(10.3%), 17 allied professionals (6.7%) and 14 doctors
(5.5%). The majority of responders had zero (32%), one
(36%) or two (18.6%) children. The ethnic origin of
responders was 50.6% White British, 18.2% Bangladeshi,
8.7% Indian, 4% White/Asian, the remaining 18.5%
made up of 12 other origins, with no one declining to dis-
close their origin.
71.5% had heard of BCG and 48.6% said they were aware
of rules governing who receives it. 63.3% of professionals
and 6.0% of parents asked said they were aware of the new
2006 policy that now governs who receives the vaccine.
Looking at parents alone, 0.0% of those who had no chil-
dren and 8.1% of those with children said they were aware
of the new policy. Table 1 shows a summary of who
responders thought receive BCG in this current policy.
When broken down, 50.0% of professionals and 0.0% of
parents asked chose the most accurate answer.
It is worth noting that this question is limited in its scope
as it does not allow a responder to give a detailed response
if they are fully aware of the new policy. However, after
piloting the questions, it was found this was the best way
of ascertaining whether responders were aware that selec-
tive neonatal vaccination is the mainstay of the new policy
and vaccination in other age groups is reserved for immi-
grants or as catch up for those missed.
40 responders had looked for further information on the
topic. Only 14 of the 40 said this information was useful.
Finally, participants were asked to make any comments
they wished. A summary of the most common responses
is shown in Table 2.
Discussion
The recent consultation by the national institute for clini-
cal excellence [8] concluded that the school program was
no longer cost effective in light of declining rates of TB in
teenagers. The new policy for selective immunisation,
shown in Table 3, offers targeted protection to newborns
based on the rates of TB in their area of the UK [9] or their
country of origin, as shown in Table 4.
Our hospital is in an area with less than 40/100,000 cases
of TB and therefore as per the policy shown in Table 3,
only new immigrant infants or infants whose parents or
Table 1: Responses when participants were asked who currently receives BCG vaccine
Response Frequency Percentage
Don't Know 166 65.6
All babies 13 5.1
Some babies 62 24.5
All teenagers 8 3.2
Some teenagers 2 0.8
Only new immigrants 2 0.8BMC Infectious Diseases 2007, 7:82 http://www.biomedcentral.com/1471-2334/7/82
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grandparents are from high risk areas should be offered
BCG.
We have found that awareness of this policy is generally
quite limited, with one third of responders not knowing
what BCG is and two thirds not knowing the current pol-
icy for vaccination. It should be noted that lack of aware-
ness of the new policy was widespread amongst
professionals as well as parents. In particular only 27% of
midwives were aware of the new policy and they are cur-
rently responsible for identifying those who need the BCG
and informing the paediatricians who administer it. This
was reflected in the comments made, with many mid-
wives stating that they need more information and knowl-
edge to inform parents effectively.
This general lack of knowledge seems to be having an
impact on parents, with a number perceiving and then
commenting that they felt the policy was racist. This is an
understandable viewpoint with a policy that apparently
vaccinates ethnic minorities with no clear explanation as
to why and limited knowledge amongst professionals
responsible for providing the relevant information. Wher-
ever in the UK knowledge amongst professionals is lim-
ited, similar problems in the perceptions of the vaccine by
parents may be seen. Also, it is also clear that when par-
ents are motivated to find information they are generally
unsatisfied (65% did not find information useful) and
this may again be due to the lack of knowledge amongst
professionals advising them.
We have discussed this with the local primary care trust
(PCT) and they are working with the new policy within
the area. They have educated all Health Visitors so that
they can identify new immigrant infants who are eligible.
In addition, all head teachers have been contacted and
school age children have been sent a questionnaire to
identify if they are eligible under the new policy. The
immunisation coordinator has informed us that this has
been well received and led to identification of many eligi-
ble children, as well as allowing concerns to be addressed.
Unfortunately, our study has shown that this education
program has not been introduced into secondary care in
the area and both parents and professionals in this sector
lack the knowledge needed to implement the new policy
effectively for neonates. In trying to improve this situa-
tion, a general program of education surrounding the new
policy and its implementation will be required for parents
antenatally and for all professionals involved in their
antenatal and postnatal care.
It has been previously suggested that vaccinating with
BCG within the community in specialist clinics has a role
[10]. This offers the advantage of being cost effective by
using entire vials of vaccine. It also allows the vaccine to
be given by someone very experienced both technically
and in terms of their knowledge and could have a positive
effect on understanding and awareness amongst parents.
It has previously been suggested that vaccinating at birth
is less effective than at three months [11], another reason
to consider community clinics as an attractive alternative
which needs further study.
Table 3: Newborn groups to be offered BCG vaccination [13]
• All babies living in areas where the incidence of TB is 40/100,000 or greater
• Babies whose parents or grandparents have lived in a country with a TB prevalence of 40/100,000 or higher
• Unvaccinated infant immigrants from countries with a high TB prevalence
Table 2: General comments recorded by participants
Comment Frequency
Would like more information 26
Appears to be a racist policy at present 15
Have tried to find out information, but not been successful 7
Know about BCG, but not current policy 6
Doesn't care 6
People around me seem very confused 5
I don't know much about it 5
Thinks all babies should be getting it 4
Policy seems correct, but implementation is not 4
Has no knowledge and concerned as has other children who might need the BCG 2
Not enough leaflets for parents 2
Should be given by trained staff in a postnatal outpatient setting 2
There are too many vaccines 2
More emphasis needed on choice 2
Confused BCG with Vitamin K 2BMC Infectious Diseases 2007, 7:82 http://www.biomedcentral.com/1471-2334/7/82
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We have shown in this study that lack of clarity as to the
reasons for selective use of BCG causes anxiety amongst
parents and it has been previously identified that white
British infants who are eligible may not be vaccinated in
such an environment [12]. Therefore, instigating a pro-
gram aimed at identifying antenatally those eligible for
BCG should increase uptake and educate all parents about
the current policy and the reasons behind it. This well
help allay concerns caused by the incorrect notion of a
'racial' factor in the use of neonatal BCG, as commented
on by several respondents in this study (Table 2).
Conclusion
We have found that amongst parents and professionals
alike there is a significant lack of knowledge of the new
BCG administration policy. In our district general hospi-
tal, this has lead to much confusion and as knowledge
amongst the professionals who identify neonates for vac-
cination is low, uptake may be sub-optimal. We suggest
that units investigate the issue and ensure that the new
policy is understood and implemented correctly. If prob-
lems are being encountered, a clear policy of antenatal
education of parents and identification of eligible babies
will ensure an appropriate uptake of BCG, as well as
addressing concerns as to the distribution of the vaccine
by the new policy by improving knowledge and under-
standing.
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